Surface Oncology
  • Home
  • About Us
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
    • Partners
  • Pipeline & Programs
    • Pipeline
    • Posters & Publications
  • Investors & Media
    • News
      • Press Releases
      • Events
    • Stock Information
      • Stock Quote Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Governance
      • Documents and Charters
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
      • SEC Filings
    • Investor Resources
      • Investor FAQs
      • Information Request
      • Email Alerts
  • Life Under the Surface
    • Social Media
    • Open Positions
  • Contact

SRF114

Publication: Fc-optimized anti-CCR8 antibody depletes regulatory T cells in human tumor models

American Association for Cancer Research, March 2021

Poster: SRF114 is a Fully Human, CCR8-Selective IgG1 Antibody that Induces Destruction of Tumor Tregs Through ADCC

Society for Immunotherapy of Cancer Annual Meeting, November 2020

Post navigation

Previous PostPrevious GSK4381562

Contact Us

50 Hampshire Street 8th Floor Cambridge, MA 02139
Surface Oncology
© 2022 Surface Oncology

SURFACE ONCOLOGY and the Surface Oncology logo are registered trademarks of Surface Oncology, Inc. All rights reserved.
50 Hampshire Street, 8th Floor
Cambridge, MA 02139
  • Privacy
  • Terms of Use
Twitter Community Guidelines
Connect with Surface
  • Twitter
  • LinkedIn
  • Instagram
  • Glassdoor
  • Home
  • About Us
  • Pipeline & Programs
  • Investors & Media
      « Back
    • Investors & Media
    • News
        « Back
      • News
      • Press Releases
      • Events
    • Stock Information
        « Back
      • Stock Information
      • Stock Quote Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Governance
        « Back
      • Governance
      • Documents and Charters
      • Board of Directors
      • Management
      • Committee Composition
    • Financial Information
        « Back
      • Financial Information
      • SEC Filings
    • Investor Resources
        « Back
      • Investor Resources
      • Investor FAQs
      • Information Request
      • Email Alerts
  • Life Under the Surface
  • Contact